 |
This article has been peer reviewed but is awaiting expert review. If you would like to help with this, please see more information about expert reviewing. |
Also known as: FIP
Description
A progressive disease of the cat caused by feline coronavirus. FIP arises from a mutation of Feline Enteric Coronavirus (FECoV) in 5-10% of chronically infected cats and not directly from cat to cat. Two forms of the disease exist the wet or exudative form and the dry or non exudative form.
Signalment
Domestic and wild cats.
Cats compromised by immunosuppression (either iatrogenic or disease-related) are at a greater risk of developing FIP.
History and Clinical signs
FECoV may cause mild respiratory symptoms and diarrhoea but is often asymptomatic.
Signs of FIP include, chronic weight loss, anorexia, pyrexia, depression, fever and vasculitis. Fluid in the abdomen, thorax or pericardium are symptomatic of wet FIP. Granulomatous change in the organs are symptomatic of dry FIP. FIP has also been documented to cause: Uveitis, hydrocephalus, neurological symptoms, such as ataxia or seizures and chronic diarrhoea.
Diagnosis
FIP should be suspected in all cases of chronic weight loss or recurrent fever unresponsive to antibiotics, particularly in multiple cat situations. Simple serology is impossible as most cats will have antibody to FECoV.
Laboratory Tests
Four indicators can be used for diagnosis:
- High FECoV Antibody titres
- Low albumin:globulin ratio in plasma/ascites (globulin levels rise in FIP)
- High levels of glycoprotein alpha 1-acid glycoprotein (AGP)
- Low white cell counts
FIP antigen detection by immunofluorescence in macrophages gives a definite positive diagnosis
Pathogenesis
Weeks, months or years may intervene between localized primary FECoV infection and FIP development. FECoV replicates in the gut, but FIP spreads systemically in the circulation. FIP then gains the ability to replicate in monocytes and macrophages.
Failure of the immune system to clear antibody-antigen complexes leads to immune-mediated disease and deposited complexes cause inflammation and exudation. This leads to characteristic oedema as fibrin-rich serum escapes to intercellular spaces.
Pyogranulomas reactions can develop in major organs as a result of the immune response and the body's failure to clear away excess neutrophils.
Cats previously exposed to coronavirus (and therefore with circulating antibody) may be at greater risk as they are more susceptible to taking up virus into mononuclear cells.
Cats making a biased Th-1 response are more likely to evade infection, whereas cats making a balanced response are at moderate risk and cats making a biased Th-2 response are at greater risk, as the virus is best tackled by cell mediation and not antibody.
Pathology
Gross
Wet form
Widespread miliary, white, pinhead granulomas and fibrin deposition, particularly in the serosa of the small and large intestine High-protein exudates can be found in peritoneal cavity.
Dry form
Larger, grey granulomatous masses are found in abdominal organs, including the small and large intestine, kidneys, liver and mesenteric lymph nodes. CNS and ocular involvement occurs in up to 60% of cases, with granulomas causing the clinical signs.
Histological
Multifocal pyogranulomas on serosa and throughout gut wall. Infiltration by mononuclear cells, lymphocytes, plasma cells, macrophages and a fewneutrophils. Necrosis and vasculitis will also be seen.
Treatment
Immunomodulators including interferon have been used to control the virus and Dr. Diane Addie at Glasgow vet school has found that cats do respond to this form of treatment.
Immunosuppressive drugs such as prednisolone or cyclophosphamide may slow disease progression.
Cats should recieve widespread antibiotics and suppotive therapy.
The disease is almost invariably fatal.
Control
Conventional vaccination is counterproductive as antibody worsens infection however a non-systemic vaccine (Primucell) is available outside the UK. Replication confined to nasal mucosa, providing local immunity and cell-mediated immunity and it cannot protect cats already infected with FECoV.
Antibody tests are available to certify FECoV-free cat houses.
Recommendations for control and prevention include:
- keeping cats in small stable groups
- good litter tray hygiene to prevent faeco-oral transmission
- reducing stress and minimising concurrent diseases
- avoid breeding from cats that previously produced kittens that succumbed to FIP.
Eliminating FIP from a cattery that has had a case is difficult, but involves closing the cattery to new arrivals and restricting movement within the buildlings. Attempts to produce FCoV-free kittens from an FCoV positing queen can be made through isolation of the queen and kittens combined with early weaning of the kittens at 5-6 weeks of age. But there is a high risk that poorly socialised kittens are produced.
Even once the cattery is free from FCoV, the long-term maintenance of this is any multicat household is extremely difficult.
Prognosis
Very poor.
| Feline Infectious Peritonitis Learning Resources | |
|---|---|
 Test your knowledge using flashcard type questions |
Small Animal Abdominal and Metabolic Disorders Q&A 13 |
Literature Search
Use these links to find recent scientific publications via CAB Abstracts (log in required unless accessing from a subscribing organisation).
Feline Infectious Peritonitis publications
References
Ettinger, S.J, Feldman, E.C. (2005) Textbook of Veterinary Internal Medicine (6th edition, volume 2) W.B. Saunders Company
Nelson, R.W. and Couto, C.G. (2009) Small Animal Internal Medicine (Fourth Edition) Mosby Elsevier